Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™

Product News   Sep 12, 2014

 
Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
 
 
FURTHER INFORMATION
 
 
 

Related Product News

LabVantage Highlights Packaged LIMS Solutions at Pittcon to Meet Industry-Specific Needs

Product News

Purpose-built, flexible LIMS solutions save time and money for pharma, food & beverage, oil & gas, and diagnostics.

READ MORE

Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Next-Generation Sequencing

Product News

New product line leverages established DNA synthesis platform to revolutionize exome and custom sequencing.

READ MORE

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News

Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards, and cell therapy.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE